Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Nuokang Bio-Pharma Given Board OK to Go Private

publication date: Sep 27, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Nuokang Bio-Pharma has accepted a go-private offer of $5.80 per ADS that values the company at $114 million. The offer comes from Yuhuan Zhu, the wife of the company's chairman/CEO, along with Grand Enterprises Group Co., Ltd., which will own 55% of the company post-transaction. Grand Enterprise is a China investment company. Nuokang’s Board has recommended that shareholders vote in favor of accepting the offer. More details....

Stock Symbol: (NSDQ: NKBP)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...